Literature DB >> 22460519

Application of Petersen Index score for Dukes'B colorectal cancer in a population of 103 consecutive resected patients.

Guido Cerullo1, Diletta Cassini, Gianandrea Baldazzi.   

Abstract

Dukes' B colorectal cancer (CRC) represents a wide spectrum of disease from early penetration through the bowel wall to aggressive and extensive tumours with extramural venous spread and involvement of the serosa, surgical margins or adjacent organs. Among Dukes' B cancers, Petersen Index allows stratification to identify those patients whom chemotherapy may benefit. One hundred and three resected patients with CRC Dukes' B were included prospectively in a database and considered in the present study. According to Petersen Index, a score (from 0 to 4) for each patient was calculated on the basis of peritoneal and margin involvement, venous invasion and tumour perforation. Twenty-four out of 103 tumours were located in the rectum and 79 in the colon. According to PI score 59 patients had a score of 0, 30 of 1 and 14 of ≥2. The overall R0 resection was achieved in 95.1 % of cases and the majority of patients with PI score of ≥2 were R1-2. The mean of harvested lymph nodes was 23.6 (±10.7) with no difference according to the PI score. Patients in the high-risk group had a worse 5-year survival rate (66.3 %) compared with the other group (P < 0.009). Multivariate analysis validated the PI score as a significant independent factor (P = 0.017). Both high-quality pathology and adequate harvested lymph nodes are needed for a proper staging. Even though the influence of PI score on survival is confirmed as it leads to an additional rate of colorectal cancer being considered for adjuvant therapy, we underline that a comparison with additional clinical and histological prognostic factors should be needed.

Entities:  

Mesh:

Year:  2012        PMID: 22460519     DOI: 10.1007/s13304-012-0146-3

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  11 in total

1.  Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence.

Authors:  G Burdy; Y Panis; A Alves; J Nemeth; A Lavergne-Slove; P Valleur
Journal:  Dis Colon Rectum       Date:  2001-11       Impact factor: 4.585

2.  Impact of age-related comorbidity on results of colorectal cancer surgery.

Authors:  Corrado Pedrazzani; Guido Cerullo; Giovanni De Marco; Daniele Marrelli; Alessandro Neri; Alfonso De Stefano; Enrico Pinto; Franco Roviello
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

3.  The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation.

Authors:  N A Shepherd; K J Baxter; S B Love
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

4.  Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination.

Authors:  P Jestin; L Påhlman; B Glimelius; U Gunnarsson
Journal:  Eur J Cancer       Date:  2005-09       Impact factor: 9.162

5.  Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial.

Authors:  Mario Prandi; Rita Lionetto; Antonio Bini; Gianfranco Francioni; Giuseppe Accarpio; Antonio Anfossi; Ezio Ballario; Giuseppe Becchi; Stefano Bonilauri; Andrea Carobbi; Paolo Cavaliere; Domenico Garcea; Lucio Giuliani; Eugenio Morziani; Franco Mosca; Antonio Mussa; Massimo Pasqualini; Domenico Poddie; Federico Tonetti; Luciano Zardo; Riccardo Rosso
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

6.  Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology.

Authors:  Eva J A Morris; Nicola J Maughan; David Forman; Philip Quirke
Journal:  Gut       Date:  2007-05-09       Impact factor: 23.059

7.  Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

Authors:  T E Le Voyer; E R Sigurdson; A L Hanlon; R J Mayer; J S Macdonald; P J Catalano; D G Haller
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

8.  Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.

Authors:  V C Petersen; K J Baxter; S B Love; N A Shepherd
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

Authors:  Deborah Schrag; Sheryl Rifas-Shiman; Leonard Saltz; Peter B Bach; Colin B Begg
Journal:  J Clin Oncol       Date:  2002-10-01       Impact factor: 44.544

10.  Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer.

Authors:  C S D Roxburgh; J E M Crozier; F Maxwell; A K Foulis; J Brown; R F McKee; J H Anderson; P G Horgan; D C McMillan
Journal:  Br J Cancer       Date:  2009-02-10       Impact factor: 7.640

View more
  1 in total

Review 1.  Prophylactic negative pressure wound therapy in colorectal surgery. Effects on surgical site events: current status and call to action.

Authors:  Gianluca Pellino; Guido Sciaudone; Francesco Selvaggi; Silvestro Canonico
Journal:  Updates Surg       Date:  2015-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.